• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

受污染的肝素与不良临床事件及接触系统激活相关。

Contaminated heparin associated with adverse clinical events and activation of the contact system.

作者信息

Kishimoto Takashi Kei, Viswanathan Karthik, Ganguly Tanmoy, Elankumaran Subbiah, Smith Sean, Pelzer Kevin, Lansing Jonathan C, Sriranganathan Nammalwar, Zhao Ganlin, Galcheva-Gargova Zoya, Al-Hakim Ali, Bailey Gregory Scott, Fraser Blair, Roy Sucharita, Rogers-Cotrone Thomas, Buhse Lucinda, Whary Mark, Fox James, Nasr Moheb, Dal Pan Gerald J, Shriver Zachary, Langer Robert S, Venkataraman Ganesh, Austen K Frank, Woodcock Janet, Sasisekharan Ram

机构信息

Momenta Pharmaceuticals, the Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology, Koch Institute for Integrative Cancer Research, Cambridge, MA 02139, USA.

出版信息

N Engl J Med. 2008 Jun 5;358(23):2457-67. doi: 10.1056/NEJMoa0803200. Epub 2008 Apr 23.

DOI:10.1056/NEJMoa0803200
PMID:18434646
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3778681/
Abstract

BACKGROUND

There is an urgent need to determine whether oversulfated chondroitin sulfate (OSCS), a compound contaminating heparin supplies worldwide, is the cause of the severe anaphylactoid reactions that have occurred after intravenous heparin administration in the United States and Germany.

METHODS

Heparin procured from the Food and Drug Administration, consisting of suspect lots of heparin associated with the clinical events as well as control lots of heparin, were screened in a blinded fashion both for the presence of OSCS and for any biologic activity that could potentially link the contaminant to the observed clinical adverse events. In vitro assays for the activation of the contact system and the complement cascade were performed. In addition, the ability of OSCS to recapitulate key clinical manifestations in vivo was tested in swine.

RESULTS

The OSCS found in contaminated lots of unfractionated heparin, as well as a synthetically generated OSCS reference standard, directly activated the kinin-kallikrein pathway in human plasma, which can lead to the generation of bradykinin, a potent vasoactive mediator. In addition, OSCS induced generation of C3a and C5a, potent anaphylatoxins derived from complement proteins. Activation of these two pathways was unexpectedly linked and dependent on fluid-phase activation of factor XII. Screening of plasma samples from various species indicated that swine and humans are sensitive to the effects of OSCS in a similar manner. OSCS-containing heparin and synthetically derived OSCS induced hypotension associated with kallikrein activation when administered by intravenous infusion in swine.

CONCLUSIONS

Our results provide a scientific rationale for a potential biologic link between the presence of OSCS in suspect lots of heparin and the observed clinical adverse events. An assay to assess the amidolytic activity of kallikrein can supplement analytic tests to protect the heparin supply chain by screening for OSCS and other highly sulfated polysaccharide contaminants of heparin that can activate the contact system.

摘要

背景

迫切需要确定硫酸皮肤素(OSCS),一种在全球范围内污染肝素供应的化合物,是否是美国和德国静脉注射肝素后发生严重类过敏反应的原因。

方法

从美国食品药品监督管理局采购的肝素,包括与临床事件相关的可疑批次肝素以及对照批次肝素,以盲法进行筛选,检测其中是否存在OSCS以及是否存在任何可能将该污染物与观察到的临床不良事件联系起来的生物活性。进行了体外接触系统激活和补体级联反应的检测。此外,还在猪身上测试了OSCS在体内重现关键临床表现的能力。

结果

在未分级肝素的污染批次中发现的OSCS,以及合成生成的OSCS参考标准品,直接激活了人血浆中的激肽-激肽释放酶途径,这可能导致生成缓激肽,一种强效血管活性介质。此外,OSCS诱导了C3a和C5a的生成,这是源自补体蛋白的强效过敏毒素。这两条途径的激活意外地相互关联,并且依赖于因子XII的液相激活。对来自不同物种的血浆样本进行筛选表明,猪和人对OSCS的作用敏感方式相似。含OSCS的肝素和合成来源的OSCS在猪静脉输注时会诱导与激肽释放酶激活相关的低血压。

结论

我们的结果为可疑批次肝素中存在OSCS与观察到的临床不良事件之间潜在的生物学联系提供了科学依据。一种评估激肽释放酶酰胺水解活性的检测方法可以补充分析检测,通过筛选OSCS和其他可激活接触系统的肝素高度硫酸化多糖污染物来保护肝素供应链。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72a5/3778681/b252a1830d46/nihms500261f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72a5/3778681/35dc56d37a0f/nihms500261f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72a5/3778681/1e9b3e1e4302/nihms500261f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72a5/3778681/72e33fb4a9fc/nihms500261f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72a5/3778681/92f3f297722b/nihms500261f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72a5/3778681/b252a1830d46/nihms500261f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72a5/3778681/35dc56d37a0f/nihms500261f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72a5/3778681/1e9b3e1e4302/nihms500261f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72a5/3778681/72e33fb4a9fc/nihms500261f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72a5/3778681/92f3f297722b/nihms500261f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72a5/3778681/b252a1830d46/nihms500261f5.jpg

相似文献

1
Contaminated heparin associated with adverse clinical events and activation of the contact system.受污染的肝素与不良临床事件及接触系统激活相关。
N Engl J Med. 2008 Jun 5;358(23):2457-67. doi: 10.1056/NEJMoa0803200. Epub 2008 Apr 23.
2
Heparin comes clean.肝素得以提纯。
N Engl J Med. 2008 Jun 5;358(23):2505-9. doi: 10.1056/NEJMe0803599.
3
Structure elucidation and biological activity of the oversulfated chondroitin sulfate contaminant in Baxter heparin.贝斯特肝素中过硫酸化软骨素污染物的结构阐明和生物活性
J Clin Pharmacol. 2010 Oct;50(10):1159-70. doi: 10.1177/0091270009355158. Epub 2010 Feb 10.
4
Heparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes.肝素诱导的过敏反应和类过敏反应:两种不同但有重叠的综合征。
Expert Opin Drug Saf. 2009 Mar;8(2):129-44. doi: 10.1517/14740330902778180.
5
Oversulfated chondroitin sulfate and OSCS-contaminated heparin cause dose- and route-dependent hemodynamic effects in the rat.过硫酸化硫酸软骨素和 OSCS 污染肝素在大鼠体内引起剂量和途径依赖性的血流动力学效应。
Toxicol Sci. 2011 Jun;121(2):417-27. doi: 10.1093/toxsci/kfr072. Epub 2011 Mar 24.
6
Contaminated heparin.受污染的肝素。
N Engl J Med. 2008 Sep 18;359(12):1292-3; author reply 1293.
7
[Anaphylactoid reactions associated with contaminated heparin from China].[与来自中国的受污染肝素相关的类过敏反应]
Ann Pharm Fr. 2011 Sep;69(5):258-64. doi: 10.1016/j.pharma.2011.06.007. Epub 2011 Aug 2.
8
Bradykinin forming capacity of oversulfated chondroitin sulfate contaminated heparin in vitro.体外研究硫酸皮肤素污染肝素的缓激肽形成能力。
Biomaterials. 2010 Aug;31(22):5741-8. doi: 10.1016/j.biomaterials.2010.03.074. Epub 2010 Apr 27.
9
The effect of increasing the sulfation level of chondroitin sulfate on anticoagulant specific activity and activation of the kinin system.增加硫酸软骨素的硫酸化程度对其抗凝血特异性活性和激肽系统激活的影响。
PLoS One. 2018 Mar 1;13(3):e0193482. doi: 10.1371/journal.pone.0193482. eCollection 2018.
10
[Artificial polysaccharide in contaminated heparin. Acute hypersensitivity reactions explained--but how could it happen?].[污染肝素中的人工合成多糖。急性过敏反应的解释——但它是如何发生的呢?]
Lakartidningen. 2008;105(39):2660-1.

引用本文的文献

1
The Road Toward Nanopore Sequencing of Glycosaminoglycans.糖胺聚糖的纳米孔测序之路
Handb Exp Pharmacol. 2025;288:109-130. doi: 10.1007/164_2025_750.
2
Expanding the recognition of monosaccharides and glycans: A comprehensive analytical approach using chemical-nose/tongue technology and a comparison to lectin microarrays.拓展对单糖和聚糖的认识:一种使用化学鼻/舌技术的综合分析方法以及与凝集素微阵列的比较。
BBA Adv. 2024 Dec 8;7:100129. doi: 10.1016/j.bbadva.2024.100129. eCollection 2025.
3
Toward acid- and heparin-free dialysis: the regional anticoagulation approach.

本文引用的文献

1
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events.过度硫酸化硫酸软骨素是肝素中的一种污染物,与不良临床事件相关。
Nat Biotechnol. 2008 Jun;26(6):669-75. doi: 10.1038/nbt1407. Epub 2008 Apr 23.
2
Acute allergic-type reactions among patients undergoing hemodialysis--multiple states, 2007-2008.2007 - 2008年多个州血液透析患者中的急性过敏样反应
MMWR Morb Mortal Wkly Rep. 2008 Feb 8;57(5):124-5.
3
The preferred pathway of glycosaminoglycan-accelerated inactivation of thrombin by heparin cofactor II.
迈向无酸和无肝素透析:局部抗凝法
Clin Kidney J. 2024 Jul 2;17(8):sfae201. doi: 10.1093/ckj/sfae201. eCollection 2024 Aug.
4
Complement-Coagulation Cross-talk: Factor H-mediated regulation of the Complement Classical Pathway activation by fibrin clots.补体-凝血交叉对话:因子 H 介导的纤维蛋白凝块对补体经典途径激活的调控。
Front Immunol. 2024 Jun 12;15:1368852. doi: 10.3389/fimmu.2024.1368852. eCollection 2024.
5
Mast cell degranulation and bradykinin-induced angioedema - searching for the missing link.肥大细胞脱颗粒与缓激肽诱导的血管性水肿——寻找缺失的环节。
Front Immunol. 2024 May 15;15:1399459. doi: 10.3389/fimmu.2024.1399459. eCollection 2024.
6
Evaluation of the Acute Anaphylactoid Reactogenicity of Nanoparticle-Containing Medicines and Vaccines Using the Porcine CARPA Model.利用猪 CARPA 模型评估含纳米颗粒的药物和疫苗的急性过敏反应原性。
Methods Mol Biol. 2024;2789:229-243. doi: 10.1007/978-1-0716-3786-9_23.
7
Synthesis of bioengineered heparin chemically and biologically similar to porcine-derived products and convertible to low MW heparin.化学合成和生物学方法制备与猪源产品类似的生物工程肝素,并可转化为低分子量肝素。
Proc Natl Acad Sci U S A. 2024 Apr 2;121(14):e2315586121. doi: 10.1073/pnas.2315586121. Epub 2024 Mar 18.
8
Validation of Recombinant Heparan Sulphate Reagents for CNS Repair.用于中枢神经系统修复的重组硫酸乙酰肝素试剂的验证
Biology (Basel). 2023 Mar 4;12(3):407. doi: 10.3390/biology12030407.
9
Analysis of Heparin Samples by Attenuated Total Reflectance Fourier-Transform Infrared Spectroscopy in the Solid State.固态下采用衰减全反射傅里叶变换红外光谱法分析肝素样品
ACS Cent Sci. 2023 Feb 14;9(3):381-392. doi: 10.1021/acscentsci.2c01176. eCollection 2023 Mar 22.
10
A site on factor XII required for productive interactions with polyphosphate.需要因子 XII 上的一个位点与多聚磷酸盐进行有效相互作用的位点。
J Thromb Haemost. 2023 Jun;21(6):1567-1579. doi: 10.1016/j.jtha.2023.02.014. Epub 2023 Mar 1.
肝素辅因子II使凝血酶糖胺聚糖加速失活的优先途径。
J Biol Chem. 2004 Mar 12;279(11):9785-95. doi: 10.1074/jbc.M313962200. Epub 2003 Dec 29.
4
Activation of the alternative pathway of complement by a phosphorothioate oligonucleotide: potential mechanism of action.硫代磷酸酯寡核苷酸对补体替代途径的激活:潜在作用机制
J Pharmacol Exp Ther. 1997 May;281(2):810-6.
5
Direct induction of complement activation by pharmacologic activation of plasminogen.通过纤溶酶原的药理学激活直接诱导补体激活。
Coron Artery Dis. 1997 Jan;8(1):9-18. doi: 10.1097/00019501-199701000-00002.
6
High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein.高分子量激肽原增强抗凝血酶对肝素加速的血浆激肽释放酶的抑制作用:抗凝血酶在激肽释放酶调节中的作用。
Biochemistry. 1993 Nov 16;32(45):12136-47. doi: 10.1021/bi00096a026.
7
Dextran sulfate activates contact system and mediates arterial hypotension via B2 kinin receptors.硫酸葡聚糖激活接触系统,并通过B2激肽受体介导动脉低血压。
J Appl Physiol (1985). 1994 Dec;77(6):2675-80. doi: 10.1152/jappl.1994.77.6.2675.
8
Autoactivation of human Hageman factor. Demonstration utilizing a synthetic substrate.人凝血因子Ⅻ的自动激活。利用合成底物的证明。
J Biol Chem. 1980 Aug 10;255(15):7281-6.
9
Activation of the classical pathway of complement by Hageman factor fragment.凝血因子片段激活补体经典途径。
J Exp Med. 1981 Mar 1;153(3):665-76. doi: 10.1084/jem.153.3.665.
10
The activation of the alternative pathway C3 convertase by human plasma kallikrein.人血浆激肽释放酶对替代途径C3转化酶的激活作用。
Immunology. 1982 Mar;45(3):587-95.